Galia Gestion is a venture capital fund based in Bordeaux and Toulouse, focusing on early-stage biotech and health tech companies. They typically invest between $500,000 and $10 million. Notably, their portfolio includes Antabio. The fund's nine-member team supports small and medium-sized enterprises in South-West France. Galia Gestion manages around 50 investments across various sectors, with a strong emphasis on biotech and health tech ventures.
